Literature DB >> 28476784

Moesin Expression Is Associated with Glioblastoma Cell Proliferation and Invasion.

Qing Wang1, Xiaojie Lu2, Shidi Zhao2, Mingzhi Pang2, Xuechao Wu2, Heng Wu3, Robert M Hoffman4,5, Zhijian Yang3, Yan Zhang2.   

Abstract

AIM: To investigate the effect of moesin expression on cell proliferaton and invasion of human glioblastoma cell lines in vitro.
MATERIALS AND METHODS: Glioblastoma LN229 and U87 cells were transfected with the H4645-plenti-EGFP-moesin expression vector for moesin up-regulation. Moesin and β-catenin expression levels in the transfected cells were analyzed by real-time polymerase chain reaction (PCR) and Western blotting. Cell proliferation was measured using the CCK8 assay. Cell invasion and migration ability were assessed using a transwell cell invasion and wound-healing assay.
RESULTS: Moesin mRNA and protein expression were significantly increased in the two transfected LN229-H4645 and U87-H4645 cell lines. β-catenin expression was increased by moesin up-regulation in the transfected LN229-H4645 and U87-H4645 cell lines. The CCK-8 assay revealed that up-regulating moesin results in a significant increase in glioblastoma cell proliferation. Glioblastoma cell invasion and migration were increased by moesin up-regulation.
CONCLUSION: Up-regulation of moesin expression in glioblastoma cells correlated with increases in cell proliferation, invasion and migration, suggesting moesin's role in glioblastoma progression. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Moesin; glioblastoma; in vitro; invasion; proliferation; silencing; up-regulation

Mesh:

Substances:

Year:  2017        PMID: 28476784     DOI: 10.21873/anticanres.11556

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Moesin (MSN) as a Novel Proteome-Based Diagnostic Marker for Early Detection of Invasive Bladder Urothelial Carcinoma in Liquid-Based Cytology.

Authors:  Jeong Hwan Park; Cheol Lee; Dohyun Han; Jae Seok Lee; Kyung Min Lee; Min Ji Song; Kwangsoo Kim; Heonyi Lee; Kyung Chul Moon; Youngsoo Kim; Minsun Jung; Ji Hye Moon; Hyebin Lee; Han Suk Ryu
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

2.  Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration.

Authors:  Fabrizio Di Giuseppe; Marzia Carluccio; Mariachiara Zuccarini; Patricia Giuliani; Lucia Ricci-Vitiani; Roberto Pallini; Paolo De Sanctis; Roberta Di Pietro; Renata Ciccarelli; Stefania Angelucci
Journal:  Biomedicines       Date:  2021-02-03

3.  Could Moesin Be a New Marker for Indicating Progression in Endometrial Cancer?

Authors:  Elif Agacayak; Aysenur Keles; Ugur Deger; Mehmet Sirin Ozcelik; Nurullah Peker; Reyhan Gunduz; Murat Akkus; Huseyin Buyukbayram
Journal:  Cancer Manag Res       Date:  2022-03-24       Impact factor: 3.989

4.  Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.

Authors:  Pinar Uysal-Onganer; Amy MacLatchy; Rayan Mahmoud; Igor Kraev; Paul R Thompson; Jameel M Inal; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

5.  A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database.

Authors:  Amrit L Pappula; Shayaan Rasheed; Golrokh Mirzaei; Ruben C Petreaca; Renee A Bouley
Journal:  Cancers (Basel)       Date:  2021-08-26       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.